FDMT
4D MolecularยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
FDMT Profile
4d Molecular Therapeutics, Inc.
A clinical-stage biotherapeutics company that develops therapies for genetic diseases
Biological Technology
03/11/2015
12/11/2020
NASDAQ Stock Exchange
227
12-31
Common stock
5858 Horton Street #455, Emeryville, CA 94608
--
4D Molecular Therapeutics, Inc., was incorporated under the laws of the State of Delaware on March 11, 2015. The Company is a leading clinical-stage biopharmaceutical company focused on unlocking the full potential of genetic medicines through proprietary custom vectors optimized for disease-specific treatments.
